Total Payments
$19,441
2024 Payments
$5,267
Companies
65
Transactions
754
Medicare Patients
709
Medicare Billing
$27,478
Payment Breakdown by Category
Food & Beverage$15,197 (78.2%)
Other$2,196 (11.3%)
Education$1,843 (9.5%)
Travel$204.27 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,197 | 717 | 78.2% |
| Education | $1,843 | 23 | 9.5% |
| Long term medical supply or device loan | $1,196 | 12 | 6.2% |
| Honoraria | $1,000 | 1 | 5.1% |
| Travel and Lodging | $204.27 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,860 | 42 | $0 (2024) |
| G1 Therapeutics, Inc. | $1,492 | 9 | $0 (2023) |
| Janssen Biotech, Inc. | $1,338 | 55 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,012 | 45 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,010 | 55 | $0 (2024) |
| Merck Sharp & Dohme LLC | $926.24 | 45 | $0 (2024) |
| Incyte Corporation | $802.24 | 33 | $0 (2024) |
| Daiichi Sankyo Inc. | $795.63 | 34 | $0 (2024) |
| Amgen Inc. | $626.88 | 27 | $0 (2023) |
| Astellas Pharma US Inc | $619.73 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,267 | 189 | Novartis Pharmaceuticals Corporation ($1,527) |
| 2023 | $6,028 | 208 | G1 Therapeutics, Inc. ($1,347) |
| 2022 | $4,503 | 201 | Amgen Inc. ($367.15) |
| 2021 | $3,644 | 156 | Celgene Corporation ($254.10) |
All Payment Transactions
754 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Geron Corporation | RYTELO (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: MYELODYSPLASTIC SYNDROME | ||||||
| 12/19/2024 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: BioOncology | ||||||
| 12/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.93 | General |
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: NONE | ||||||
| 12/05/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: BioOncology | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Oncology | ||||||
| 11/25/2024 | Agios Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.60 | General |
| 11/22/2024 | BeiGene USA, Inc. | TEVIMBRA (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Oncology | ||||||
| 11/21/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $117.04 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/16/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $112.43 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $29.43 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $1.38 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Novocure Inc. | Optune Lua (NovoTTF-200T) (Device) | Food and Beverage | Cash or cash equivalent | $13.75 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $32.18 | General |
| Category: Hematology | ||||||
| 10/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.63 | General |
| 10/17/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 463 | 753 | $90,841 | $18,911 |
| 2022 | 6 | 175 | 203 | $20,740 | $3,796 |
| 2021 | 2 | 44 | 52 | $11,425 | $3,590 |
| 2020 | 2 | 27 | 29 | $3,927 | $1,181 |
Total Patients
709
Total Services
1,037
Medicare Billing
$27,478
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 94 | $23,500 | $7,317 | 31.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 39 | $9,750 | $2,886 | 29.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $8,330 | $1,866 | 22.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 11 | 21 | $10,164 | $1,655 | 16.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 82 | 143 | $4,290 | $1,201 | 28.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 80 | 138 | $10,350 | $1,050 | 10.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 70 | 101 | $7,575 | $1,045 | 13.8% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 12 | 42 | $7,560 | $744.90 | 9.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 34 | $2,550 | $299.20 | 11.7% |
| 82378 | Carcinoembryonic antigen (cea) protein level | Office | 2023 | 11 | 13 | $1,300 | $241.54 | 18.6% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 14 | 16 | $1,360 | $213.76 | 15.7% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 19 | 26 | $1,950 | $153.92 | 7.9% |
| 83550 | Iron binding capacity | Office | 2023 | 11 | 13 | $975.00 | $111.41 | 11.4% |
| 83540 | Iron level | Office | 2023 | 11 | 13 | $975.00 | $82.42 | 8.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 14 | 20 | $120.00 | $25.29 | 21.1% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 12 | 23 | $92.00 | $18.36 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 34 | $8,500 | $2,505 | 29.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 45 | 53 | $3,975 | $397.56 | 10.0% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 11 | 19 | $3,420 | $339.42 | 9.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 31 | 32 | $2,400 | $332.04 | 13.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 45 | 54 | $1,620 | $156.81 | 9.7% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2022 | 11 | 11 | $825.00 | $65.24 | 7.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 31 | $7,750 | $2,451 | 31.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 21 | $3,675 | $1,138 | 31.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 13 | $2,170 | $727.11 | 33.5% |
About Jeffrey Taylor, NP
Jeffrey Taylor, NP is a Family healthcare provider based in Greeneville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2016. The National Provider Identifier (NPI) number assigned to this provider is 1518329028.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jeffrey Taylor, NP has received a total of $19,441 in payments from pharmaceutical and medical device companies, with $5,267 received in 2024. These payments were reported across 754 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($15,197).
As a Medicare-enrolled provider, Taylor has provided services to 709 Medicare beneficiaries, totaling 1,037 services with total Medicare billing of $27,478. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Greeneville, TN
- Active Since 03/23/2016
- Last Updated 04/07/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1518329028
Products in Payments
- COSELA (Drug) $1,492
- KISQALI (Drug) $1,455
- KEYTRUDA (Biological) $850.36
- DARZALEX (Biological) $691.40
- OPDIVO (Biological) $534.55
- JAKAFI (Drug) $462.45
- REBLOZYL (Biological) $447.75
- VENCLEXTA (Drug) $434.69
- LIBTAYO (Biological) $407.97
- Lenvima (Drug) $406.44
- Enhertu (Drug) $365.55
- INJECTAFER (Drug) $335.53
- BRUKINSA (Drug) $327.14
- IMBRUVICA (Drug) $270.75
- NINLARO (Drug) $265.75
- KRAZATI (Drug) $251.79
- ELITEK (Biological) $251.63
- FOTIVDA (Drug) $215.45
- VERZENIO (Drug) $193.12
- CALQUENCE (Drug) $191.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Greeneville
Kimberly Hoyle, Fnp-C, FNP-C
Family — Payments: $9,440
Family $9,440
Ms. Ashley Carr, Apn, APN
Family — Payments: $9,383
Family $9,383
Sarah Whitaker, Np, NP
Family — Payments: $7,367
Family $7,367
Nikki Greer-Collier, Fnp-Bc, FNP-BC
Family — Payments: $6,535
Family $6,535
Holly Mcgaw
Family — Payments: $5,052
Family $5,052
Saprina Fender, Anp, ANP
Family — Payments: $4,058
Family $4,058